Avtor/Urednik		Simic Jovicic, Marijana; Pušić, Maja; Antunović, Maja; Ledinski, Maja; Librenjak, Lucija; Kulundžić, Robert; Ribičić, Tomislav; Trkulja, Vladimir; Urlić, Inga
Naslov		In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells
Tip		članek
Vol. in št.		Letnik 72, št. 4
Leto izdaje		2022
Obseg		str. 599-613
ISSN		1330-0075 - Acta pharmaceutica (Zagreb, Croatia)
Jezik		eng
Abstrakt		Stagnation in novelties of osteosarcoma (OS) treatment indi- cates the need for new therapeutic methods. OS cancer stem cells (OS-CSC) are taught to have the ability to self-renew and develop mechanisms of anticancer drug resistance, and this is why it is difficult to eradicate them. Their metabolism has been recognized as a potential target of therapeutic action. Ascorbic acid (AA) is considered to act pro-oxidative against OS-CSC in vitro by oxidative effect and by inhibition of glycolysis. This study examined an in vitro impact of AA on OS-CSC metabolism isolated from patients’ biopsies, with the aim of better understanding of OS-CSC metabolism and the action of AA on OS-CSC. OS-CSC were isolated using a sphere culture system and identified as stem cells using Hoechst 33342 exclusion assay. Determination of the dominant type of metabolism of OS-CSC, parental OS cells, human mesenchymal stem cells (hMSC) and U2OS OS lin- eage before and after AA treatment was done by Seahorse XF (Agilent). Cytotoxicity of high-dose AA was confirmed by the MTT test and was proven for all the examined cell types as well as HEK293. Seahorse technology showed that OS-CSC can potentially use both glycolysis and oxidative phosphorylation (OXPHOS), and can turn to glycolysis and slow metabolic potential in unfavorable conditions such as incubation in AA.
Proste vsebinske oznake		osteosarcoma cancer stem cells tumor cell metabolism osteosarkom matične celice raka presnova tumorskih celic